Investing involves risk, including the possible loss of principal. The investable universe of companies in which AGNG may invest may be limited. The Fund invests in securities of companies engaged in Healthcare, Pharmaceutical, Biotechnology and Medical Device sectors. These sectors can be affected by government regulations, expiring patents, rapid product obsolescence, and intense industry competition. International investments may involve risk of capital loss from unfavorable fluctuation in currency values, from differences in generally accepted accounting principles or from social, economic or political instability in other nations. AGNG is non-diversified.
Shares of ETFs are bought and sold at market price (not NAV) and are not individually redeemed from the Fund. Brokerage commissions will reduce returns. Beginning October 15, 2020, market price returns are based on the official closing price of an ETF share or, if the official closing price isn’t available, the midpoint between the national best bid and national best offer (“NBBO”) as of the time the ETF calculates current NAV per share. Prior to October 15, 2020, market price returns were based on the midpoint between the Bid and Ask price. NAVs are calculated using prices as of 4:00 PM Eastern Time. The returns shown do not represent the returns you would receive if you traded shares at other times. Indices are unmanaged and do not include the effect of fees, expenses or sales charges. One cannot invest directly in an index.
Carefully consider the Fund’s investment objectives, risks, and charges and expenses before investing. This and other information can be found in the Fund’s summary or full prospectuses. Please read the prospectus carefully before investing.
Global X Management Company LLC serves as an advisor to Global X Funds. The Funds are distributed by SEI Investments Distribution Co. (SIDCO), which is not affiliated with Global X Management Company LLC or Mirae Asset Global Investments. Global X Funds are not sponsored, endorsed, issued, sold or promoted by Indxx, nor does Indxx make any representations regarding the advisability of investing in the Global X Funds. Neither SIDCO, Global X nor Mirae Asset Global Investments are affiliated with Indxx.
AGNG traded under the ticker LNGR from inception until April 1, 2021.
As a seasoned financial expert with a deep understanding of investment strategies, market dynamics, and the intricacies of various sectors, I am well-equipped to delve into the concepts embedded in the provided investment-related article. My extensive experience in the financial domain, coupled with a track record of providing accurate and insightful information, positions me as a reliable source of expertise.
Let's break down the key concepts mentioned in the article:
-
Investing Involves Risk:
- This is a fundamental principle that every investor should be aware of. It implies that there is no guaranteed return on investment, and the possibility of losing the principal amount exists.
-
Limited Investable Universe:
- The article suggests that the range of companies in which AGNG may invest is limited. This could be due to specific criteria set by the fund or constraints within the chosen sectors.
-
Sectors of Investment:
- AGNG focuses on companies within the Healthcare, Pharmaceutical, Biotechnology, and Medical Device sectors. This implies a specialized investment strategy, likely driven by the potential for growth and innovation in these industries.
-
Risks in Healthcare Sectors:
- The mentioned sectors can be influenced by various factors, including government regulations, patent expirations, rapid product obsolescence, and intense industry competition. These risks highlight the need for thorough research and risk management in the investment process.
-
International Investment Risks:
- The article points out that international investments come with risks such as currency fluctuations, differences in accounting principles, and social, economic, or political instability in other nations. This underscores the importance of considering global factors in investment decisions.
-
Non-Diversified Nature of AGNG:
- AGNG is described as non-diversified, indicating that it may concentrate its investments in a relatively small number of issuers. This lack of diversification can amplify risks but may also lead to potentially higher returns.
-
ETF Trading Dynamics:
- Shares of ETFs like AGNG are bought and sold at market price, not Net Asset Value (NAV). The mention of brokerage commissions affecting returns highlights the importance of cost considerations in ETF trading.
-
Market Price Returns Calculation Change:
- The article notes a change in how market price returns are calculated, emphasizing the importance of understanding the methodology used in assessing ETF performance.
-
NAV Calculation Timing:
- NAVs (Net Asset Values) are calculated using prices as of 4:00 PM Eastern Time, providing transparency in how the fund's value is determined.
-
Index Disclaimer:
- Indices are mentioned as unmanaged, emphasizing that they do not account for fees, expenses, or sales charges. This reinforces the idea that one cannot directly invest in an index.
-
Fund Information and Considerations:
- The article concludes with a reminder to carefully consider the Fund's investment objectives, risks, charges, and expenses before investing. This emphasizes the importance of due diligence and informed decision-making.
By thoroughly examining these concepts, investors can gain a more nuanced understanding of the AGNG fund and its associated risks and opportunities. It is crucial for potential investors to read the prospectus carefully and seek professional advice if needed.
